⏳ Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Bluebird bio Inc (0HOH)

London
Currency in USD
0.40
0.00(0.00%)
Real-time Data
0HOH Scorecard
Full Analysis
Operates with a significant debt burden
Fair Value
Day's Range
0.350.40
52 wk Range
0.291.42
Key Statistics
Edit
Prev. Close
-
Open
0.4
Day's Range
0.35-0.4
52 wk Range
0.29-1.42
Volume
-
Average Volume (3m)
46.79K
1-Year Change
-99.52%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0HOH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
2.36
Upside
+220.13%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Bluebird bio Inc Company Profile

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company’s product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Its clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.

Employees
375

Compare 0HOH to Peers and Sector

Metrics to compare
0HOH
Peers
Sector
Relationship
P/E Ratio
−0.5x−1.5x−0.7x
PEG Ratio
0.00−0.010.00
Price/Book
−24.7x1.8x2.6x
Price / LTM Sales
2.7x6.8x3.2x
Upside (Analyst Target)
-314.8%45.9%
Fair Value Upside
Unlock6.5%7.6%Unlock

FAQ

What Is the Bluebird (0HOH) Stock Price Today?

The Bluebird stock price today is 0.40

What Stock Exchange Does Bluebird Trade On?

Bluebird is listed and trades on the London stock exchange.

What Is the Stock Symbol for Bluebird?

The stock symbol for Bluebird is "0HOH."

What Is the Bluebird Market Cap?

As of today, Bluebird market cap is 143.17M.

What is Bluebird Earnings Per Share?

The Bluebird EPS is -1.67.

What Is the Next Bluebird Earnings Date?

Bluebird will release its next earnings report on 24 Feb 2025.

From a Technical Analysis Perspective, Is 0HOH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.